Cranial repair using BMP-2 gene engineered bone marrow stromal cells

Journal of Surgical Research

Volumn 119, Issue 1, 2004, Pages 85-91

  Chang, Sophia Chia Ning ^a,e   Chuang, Huoli ^b   Chen, Yu Ray ^a   Yang, Lin Cheng ^a   Chen, Jan Kan ^c   Mardinis, Samir ^a   Chung, Hui Ying ^c   Lu, Yi Lung ^c   Ma, Wei Chun ^c   Lou, Jueren ^d  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b MACKAY MEMORIAL HOSPITAL   (Taiwan)

^c CHANG GUNG UNIVERSITY   (Taiwan)

^d WASHINGTON UNIVERSITY   (United States)

^e CHANG GUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

Author keywords

BMP 2; bone marrow mesenchymal stromal cell; MSC; tissue engineering

Indexed keywords

ALGINIC ACID; BONE MORPHOGENETIC PROTEIN 2; POLYMER;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASPIRATION; BONE MARROW CELL; CELL SEPARATION; CONTROLLED STUDY; DURA MATER; GENE REPLICATION; GENETIC ENGINEERING; HISTOLOGY; ILIAC CREST; IMPLANTATION; MESENCHYME CELL; MONOLAYER CULTURE; NONHUMAN; PERIOSTEUM; PRIORITY JOURNAL; RABBIT; SKULL DEFECT; SKULL SURGERY; STROMA CELL;

ADENOVIRIDAE; ANIMALS; BONE DISEASES; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; BONE MORPHOGENETIC PROTEINS; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; IMAGING, THREE-DIMENSIONAL; RABBITS; RECOMBINANT PROTEINS; SKULL; STROMAL CELLS; TISSUE ENGINEERING; TOMOGRAPHY, X-RAY COMPUTED; TRANSFORMING GROWTH FACTOR BETA;

EID: 2342458374     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jss.2003.08.003     Document Type: Article

References (44)

1. Langer R., Vacanti J.P. Tissue engineering. Science. 920:1993;260
2. Zegzula H.D., Buck D.C., Brekke J., Wozney J.M., Hollinger J.O. Bone formation with use of rhBMP-2 (recombinant human bone morphogenetic protein-2). J. Bone Joint Surg. Am. 79:1997;1778
3. Rabie A.B., Chay S.H., Wong A.M. Healing of autogenous intramembranous bone in the presence and absence of homologous demineralized intramembranous bone. Am. J. Orthod. Dentofacial Orthop. 117:2000;288
4. Niederwanger M., Urist M.R. Demineralized bone matrix supplied by bone banks for a carrier of recombinant human bone morphogenetic protein (rhBMP-2) A substitute for autogeneic bone grafts. J. Oral Implantol. 22:1996;210
5. Furukawa T., Matsusue Y., Yasunaga T., Nakagawa Y., Okada Y., Shikinami Y., Okuno M., Nakamura T. Histomorphometric study on high-strength hydroxyapatite/poly(L-lactide) composite rods for internal fixation of bone fractures. J. Biomed. Mater. Res. 50:2000;410
6. Metcalf D. The molecular control of cell division, differentiation commitment and maturation in haemopoietic cells. Nature. 339:1989;27
7. Wiles M.V., Keller G. Multiple hematopoietic lineages develop from embryonic stem (ES) cells in culture. Development. 111:1991;259
8. Goshima J., Goldberg V.M., Caplan A.I. The origin of bone formed in composite grafts of porous calcium phosphate ceramic loaded with marrow cells. Clin. Orthop. 269:1991;274
9. Ahrens M., Ankenbauer T., Schroder D., Holinagel A., Mayer H., Gross G. Expression of human bone morphogenetic proteins 2 or 4 in murine mesenchymal progenitor C3H10T1/2 cells induces differentiation into distinct mesenchymal cell lineage. DNA Cell Biol. 12:1993;871
10. Gitelman S.E., Kobrin M.S., Ye J.Q., Lopez A.R., Lee A., Derynck R. Recombinant Vgr-1/BMP6-expression tumors induce fibrosis and endochondral bone formation in vivo. J. Cell Biol. 126:1994;1595
11. Katagiri T., Yamaguchi A., Komaki M., Abe E., Takahashi N., Ikeda T., Rosen V., Wozney J.M., Fujisawa-Sehara A., Suda T. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J. Cell Biol. 127:1994;1755
12. Rosen V., Nove J., Song J.J., Thies R.S., Cox K., Wozney J.M. Responsiveness of clonal limb bud cell lines to bone morphogenetic protein 2 reveals a sequential relationship between cartilage and bone cell phenotypes. J. Bone Miner. Res. 9:1994;1759
13. Yamaguchi A., Katagiri T., Ikeda T., Wozney J.M., Rosen V., Wang E.A., Kahn A.J., Suda T., Yoshiki S. Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro. J. Cell Biol. 113:1991;681
14. Gerhart T.N., Kirker-Head C.A., Kriz M.J., Holtrop M.E., Hennig G.E., Hipp J., Schelling S.H., Wang E. Healing segmental femoral defects in sheep using recombinant human bone morphogenetic protein. Clin. Orthop. 293:1993;317
15. Lou J., Xu F., Merkel K., Manske P. Gene therapy Adenovirus-mediated human bone morphogenetic protein-2 gene transfer induces mesenchymal progenitor cell proliferation and differentiation in vitro and bone formation in vivo. J. Orthop. Res. 17:1999;43
16. Lazarus H.M., Haynesworth S.E., Gerson S.L., Rosenthal N.S., Caplan A.I. Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells) Implications for therapeutic use. Bone Marrow Transplant. 16:1995;557
17. Lou J., Manske P.R., Aoki M., Joyce M.E. Adenovirus-mediated gene transfer into tendon and tendon sheath. J. Orthop. Res. 14:1996;513
18. Lo L.J., Marsh J.L., Vannier M.W., Patel V.V. Craniofacial computer assisted surgical planning and simulation. Clin. Plast. Surg. 21:1994;501
19. Robb R.A., Hanson D.P. A software system for interactive and quantitative visualization of multidimensional biomedical images. Australas. Phys. Eng. Sci. Med. 14:1991;9
20. Heise C., Sampson-Johannes A., Williams A., McCormick F., Von Hoff D.D., Kirn D.H. ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents. Nat. Med. 3:1997;639
21. Yasko A.W., Lane J.M., Fellinger E.J., Rosen V., Wozney J.M., Wang E.A. The healing of segmental defects, induced by recombinant human bone morphogenetic protein (rhBMP-2) A radiographic, histological, and biomechanical study in rats. J. Bone Joint Surg. 74:1992;659
22. Muschler G.F., Hyodo A., Manning T., Kambic H., Easley K. Evaluation of human bone morphogenetic protein 2 in a canine spinal fusion model. Clin. Orthop. 308:1994;229
23. Preece A. A Manual for Histologic Technicians. 1972;57-73 Little, Brown, and Co, Boston
24. Toriumi D.M., Kotler H.S., Luxenberg D.P., Holtrop M.E., Wang E.A. Mandibular reconstruction with a recombinant bone-inducing factor Functional, histologic, and biomechanical evaluation. Arch. Otolaryngol. Head Neck Surg. 117:1991;1101
25. Cook S.D., Dalton J.E., Tan E.H., Whitecloud T.S. 3rd, Rueger D.C. In vivo evaluation of recombinant human osteogenic protein implants as a bone graft substitute for spinal fusions. Spine. 19:1994;1655
26. Wang E.A., Rosen V.D., Alessandro J.S., Bauduy M., Cordes P., Harada T., Israel D.I., Hewick R.M., Kerns K.M., LaPan P. Recombinant human bone morphogenetic protein induces bone formation. Proc. Natl. Acad. Sci. USA. 87:1990;2220
27. Crystal R.G. Transfer of genes to humans Early lessons and obstacles to success. Science. 270:1995;404
28. Roman M., Axelrod J.H., Dai Y., Naviaux R.K., Friedmann T., Verma I.M. Circulating human or canine factor IX from retrovirally transduced primary myoblasts and established myoblast cell lines grafted in murine skeletal muscle. Somat. Cell Mol. Genet. 18:1992;247
29. Resenfeld M.A., Yoshimura K., Trapnel B.C., Yoneyama K., Rosenthal E.R., Dalemans W., Fukayama M., Bargon J., Stier L.E., Stratford-Perricaudet L., Perricaudet M., Guggino W.B., Pavirani A., Lecocq J.P., Crystal R.G. In vivo transfer of the human cystic fibrosis transmembrane conductance gene to the airway epithelium. Cell. 68:1992;143
30. Wilson J.M. Adenoviruses as gene-delivery vehicles. N. Engl. J. Med. 334:1996;1185
31. Nakahara H., Bruder S.P., Goldberg V.M., Caplan A.I. In vivo osteochondrogenic potential of cultured cells derived from the periosteum. Clin. Orthop. Relat. Res. 259:1990;223
32. Isogai N., Landis W.J., Mori R., Gotoh Y., Gerstenfeld L.C., Upton J., Vacanti J.P. Experimental use of fibrin glue to induce site-directed osteogenesis from cultured periosteal cells. Plast. Reconstr. Surg. 105:2000;953
33. Breitbart A.S., Grande D.A., Kessler R., Ryaby J.T., Fitzsimmons R.J., Grant R.T. Tissue engineered bone repair of calvarial defects using cultured periosteal cells. Plast. Reconstr. Surg. 101:1998;567-575. (discussion)
34. Vacanti C.A., Kim W., Upton J., Moonet D., Vacanti J.P. The efficacy of periosteal cells compared to chondrocytes in the tissue engineered repair of bone defects. Tissue Eng. 1:1995;301
35. Chaplin J.M., Costantino P.D., Wolpoe B.A., Bederson J.B., Sy Griffery E., Zhang W.X. Use of an acellular dermal allogeraft for dural replacement An experimental study. Neurosurgery. 45:1999;320
36. Rowley J.A., Madlambayan G., Mooney D.J. Alginate hydrogels as synthetic extracellular matrix materials. Biomaterials. 20:1999;45
37. Chang S.C.N., Rowley J.A., Tobias G., Genes N.G., Roy A.K., Mooney D.J., Vacanti C.A., Bonassar L.J. Injection molding of alginate/chondrocyte constructs in the shape of facial implants. J. Biomed. Mater. Res. 55:2001;503
38. Quinn T.M., Grodzinsky A.J. Longitudinal modulus and hydraulic permeability of poly(methacrylic acid) gels Effects of charge density and solvent content. Macromolecules. 26:1993;4332
39. Dard M., Sewing A., Meyer J., Verrier S., Roessler S., Scharnweber D. Tools for tissue engineering of mineralized oral structures. Clin. Oral Invest. 4:2000;126
40. Paige K.T., Cima L.G., Yaremchuk M.J., Vacanti J.P., Vacanti C.A. Injectable cartilage. Plast. Reconstr. Surg. 96:1995;1390-1399. (discussion)
41. Paige K.T., Cima L.G., Yaremchuk M.J., Schloo B.L., Vacanti J.P., Vacanti C.A. De novo cartilage generation using calcium alginate-chondrocyte constructs. Plast. Reconstr. Surg. 97:1996;168-179. (discussion)
42. Beresford J.N. Osteogenic stem cells and the stromal system of bone and marrow. Clin. Orthop. 240:1989;270
43. Caplan A.I. Mesenchymal stem cell-mediated cartilage and bone repair. Biological Mechanisms of Tooth Movement and Craniofacial Adaptation. 1992;. Proceedings of the International Conference Held at the Great Southern Hotel, Columbus, Ohio
44. Haynesworth S.E., Goshima J., Goldberg V.M., Caplan A.I. Characterization of cells with osteogenic potential from human marrow. Bone. 13:1992;81